Traphagen Investment Advisors LLC Increases Holdings in The Procter & Gamble Company (NYSE:PG)

Traphagen Investment Advisors LLC raised its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 7.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,499 shares of the company’s stock after purchasing an additional 308 shares during the period. Traphagen Investment Advisors LLC’s holdings in Procter & Gamble were worth $742,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in PG. Advantage Trust Co bought a new position in Procter & Gamble in the fourth quarter worth approximately $28,000. Transcendent Capital Group LLC purchased a new stake in shares of Procter & Gamble during the 4th quarter worth $31,000. Ruedi Wealth Management Inc. boosted its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares in the last quarter. Criterion Capital Advisors LLC purchased a new position in Procter & Gamble in the fourth quarter valued at about $33,000. Finally, MeadowBrook Investment Advisors LLC bought a new position in Procter & Gamble in the fourth quarter worth about $33,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 0.2 %

Shares of NYSE PG traded down $0.37 during mid-day trading on Thursday, reaching $169.79. 2,146,596 shares of the company’s stock were exchanged, compared to its average volume of 7,812,002. The firm has a market capitalization of $400.73 billion, a price-to-earnings ratio of 27.74, a PEG ratio of 3.64 and a beta of 0.41. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $171.89. The company’s 50-day moving average is $167.17 and its 200-day moving average is $163.50. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s revenue was down .1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.37 EPS. Analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Activity

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the completion of the sale, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. The disclosure for this sale can be found here. Over the last quarter, insiders sold 84,389 shares of company stock valued at $14,373,932. 0.17% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Stifel Nicolaus raised their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. TD Cowen assumed coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective for the company. JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 31st. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Citigroup lifted their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $173.95.

Check Out Our Latest Stock Analysis on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.